people · May 16, 2026
Profound Medical Shareholders Approve Director Elections and LTIP at May 13, 2026 Meeting
Share the canonical public link.
Profound Medical Corp. held its 2026 Annual General and Special Meeting of Shareholders on May 13, 2026. Shareholders elected eight directors, including two new nominees, with individual director support ranging from 79% to 91% of votes cast. They approved PricewaterhouseCoopers LLP as auditors with 25,193,910 votes for and 99.497% support. Shareholders also approved an ordinary resolution confirming unallocated restricted share units and deferred share units under the long-term incentive plan, with 9,046,376 votes for and 63.922% support. The company had 36,337,637 common shares outstanding as of April 2, 2026. Executive compensation details include Arun Menawat as CEO and Director.
Spend governor blocked model creation: provider_circuit_open (lane=dev, provider=together)